JACLYNN WILKERSON: Open Payments
NPI 1598213175 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,490 in 75 payments from 26 companies in 2025. Trend: 2023 $1,284 · 2024 $1,364 · 2025 $1,490
Food & beverage: $1,490
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 12 | $239 |
| Ascendis Pharma Endocrinology Inc | 8 | $221 |
| SANOFI-AVENTIS U.S. LLC | 6 | $143 |
| Novartis Pharmaceuticals Corporation | 8 | $140 |
| Lilly USA, LLC | 7 | $124 |
| Chiesi USA, Inc. | 4 | $86 |
| Ascensia Diabetes Care Us Inc. | 5 | $84 |
| Tandem Diabetes Care, Inc. | 3 | $73 |
| Novo Nordisk Inc | 3 | $49 |
| Radius Health, Inc. | 2 | $35 |
Products named: Yorvipath, TZIELD, LEQVIO, EVENITY, REPATHA, JARDIANCE, t:slim X2 Insulin Pump with Control-IQ, MYCAPSSA.
Industry payments across UT — which companies pay providers there.
